Michael Samar

Michael Samar

Directeur/Bestuurslid bij
Outbio Bay Area, Inc.
53 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Michael P.
Samar
currently works at Outbio Bay Area, Inc., as Treasurer & Director.
Mr. Samar also formerly worked at Onyx Pharmaceuticals, Inc., as Director-Financial Planning & Analysis in 2013, Agennix, Inc., as Senior Finance Director-Global Planning & Analysis from 2005 to 2013, Unity Biotechnology, Inc., as Independent Director from 2022 to 2025, Acorda Therapeutics, Inc., as Vice President-Finance from 2014 to 2017, Johnson & Johnson Pharmaceutical Research & Development LLC, as Principal from 1999 to 2005, Windgap Medical, Inc., as Chief Financial Officer from 2023 to 2024, Assembly Biosciences, Inc., as Chief Financial & Accounting Officer from 2021 to 2022, and Assembly Biosciences, Inc., as Chief Financial Officer.
Mr. Samar received his Masters Business Admin degree from Villanova University and undergraduate degree from Bryant University.

Actieve functies van Michael Samar

BedrijvenFunctieBegin
Outbio Bay Area, Inc.
Directeur/Bestuurslid -

Eerdere bekende functies van Michael Samar

BedrijvenFunctieEinde
UNITY BIOTECHNOLOGY, INC. Directeur/Bestuurslid 27-06-2025
Financieel Directeur/CFO 01-12-2024
ASSEMBLY BIOSCIENCES, INC. Financieel Directeur/CFO 12-08-2022
ACORDA THERAPEUTICS, INC. Financieel Directeur/CFO 01-04-2017
Corporate Officer/Principal 01-12-2013
Ervaring van Michael Samar in detail bekijken

Opleiding van Michael Samar

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

63

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Outbio Bay Area, Inc.

  1. Beurs
  2. Insiders
  3. Michael Samar
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU